ADBiotech Co

ADBiotech Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 39.91 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 51.46 % — a change of -22.45% (lower).

Cash Conversion

39.91 %

YoY

-22.45%

Last updated:

Cash Conversion Rate (OCF/Net Income) of ADBiotech Co is 2025 39.91 % . Cash Conversion Rate (OCF/Net Income) of ADBiotech Co was 2024 51.46 % . It decreases by -22.45% lower compared to the previous year.

The ADBiotech Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
-3.58 KRW
Jan 1, 2019
-19.23 KRW
Jan 1, 2020
13.88 KRW
Jan 1, 2021
81.13 KRW
Jan 1, 2022
-318.68 KRW
Jan 1, 2023
-11.00 KRW
Jan 1, 2024
51.46 KRW
Jan 1, 2025
39.91 KRW
The ADBiotech Co Cash Conversion history
YEARCash ConversionYoY
39.91 %-22.45%
51.46 %-567.86%
-11.00 %-96.55%
-318.68 %-492.82%
81.13 %+484.57%
13.88 %-172.15%
-19.23 %+436.83%
-3.58 %-101.91%
187.87 %+126.49%
82.95 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Cash Conversion Rate (OCF/Net Income) of ADBiotech Co is 39.91 % in 2025.

Cash Conversion Rate (OCF/Net Income) of ADBiotech Co changed from 51.46 % to 39.91 %, representing a -22.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ADBiotech Co

All Key Metrics — ADBiotech Co